Delivery Order SPE2DB20D1109-SPE2DB25FP16R
- Not listed
- The Defense Logistics Agency awarded a $28,123.08 delivery order to AmerisourceBergen Drug Corp for TEZSPIRE 210 mg/1.91 ml pen auto-injectors on September 2, 2025, with completion targeted for September 23, 2025. This firm fixed-price contract represents a direct delivery order with no set-aside designation, utilizing open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $4,687.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TEZSPIRE 210 mg/1.91 mL pen auto-injectors on August 28, 2025, with a completion date of September 19, 2025. This non-set-aside competitive award is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $7,030.77 delivery order to AmerisourceBergen Drug Corp for TEZSPIRE 210 mg/1.91 ml pen auto-injectors on September 3, 2025, with an ultimate completion date of September 24, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,343.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TEZSPIRE 210 mg/1.91 ml pen auto-injectors, with an ultimate completion date of September 8, 2025. This non-set-aside, competitively awarded contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $2,343.59 to AmerisourceBergen Drug Corp on July 21, 2025, for TEZSPIRE 210 mg/1.91 mL pen auto-injectors. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of August 11, 2025. The contract will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,030.77 to AmerisourceBergen Drug Corp for TEZSPIRE 210 MG/1.91 ML pen auto-injectors on September 9, 2025, with completion targeted for September 30, 2025. The contract utilizes firm fixed pricing with no small business set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and...
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of TEZSPIRE 210 mg/1.91 mL pen injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of May 15, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,687.18 to AmerisourceBergen Drug Corp for TEZSPIRE 210 mg/1.91 mL pen auto-injectors. This firm fixed-price, non-set-aside contract was awarded on July 31, 2025, with an ultimate completion date of August 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, where this order will be performed, is a major pharmaceutical distributor serving federal medical procurement needs. The delivery order operates...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 18, 2025, with a ceiling value of $28,123.08 for TEZSPIRE 210 mg/1.91 ml pen injectors. This firm fixed price, non-competitive delivery order is funded by the Defense Logistics Agency's Medical Supply Chain division and is scheduled for completion by October 9, 2025. The award represents a child contract under AmerisourceBergen's significant...
- The Defense Logistics Agency awarded a $2,343.59 firm fixed price delivery order to AmerisourceBergen Drug Corp for TEZSPIRE 210 mg/1.91 ml pen auto-injectors, with an ultimate completion date of September 30, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement that runs through December 2026. The pharmaceutical distributor,...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP16RDelivery Order
The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp for TEZSPIRE 210 mg/1.91 mL pen auto-injectors on June 2, 2025, with completion scheduled for June 24, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical procurement and holds a significant role in supporting military and veteran healthcare systems. The performance location for this order is the company's corporate office in Conshohocken, PA. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. TEZSPIRE is a biologic medication indicated for severe eosinophilic asthma, representing the type of specialty pharmaceutical products the prime vendor contract is designed to supply across military healthcare programs. The broader IDC vehicle enables AmerisourceBergen to fulfill pharmaceutical needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally, with the contract encompassing brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 6/2/25 |